ATE293113T1 - NEW POLYMORPHIC FORMS OF OLANZAPINE

29 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims
Document	Office	Kind	Date
977BO1999	India	A	1999-12-28
54074900	United States of America	A	2000-03-31
0004982	United Kingdom	W	2000-12-22

Family members, oldest first
Document	Office	Kind
CA2395774A1	Canada	A1	2001-07-05
WO0147933A1	World Intellectual Property Organization (WIPO)	A1	2001-07-05
AU2017601A	Australia	A	2001-07-09
US6348458B1	United States of America	B1	2002-02-19
IN187439B	India	B	2002-04-27
EP1246827A1	European Patent Office (EPO)	A1	2002-10-09
US2002165225A1	United States of America	A1	2002-11-07
DE20023184U1	Germany	U1	2003-04-03
DK200300161U1	Denmark	U1	2003-06-16
ZA200205228B	South Africa	B	2003-06-30
DK200300221U1	Denmark	U1	2003-08-25
DK200300222U1	Denmark	U1	2003-08-25
DK200300161U3	Denmark	U3	2003-12-12
DK200300221U3	Denmark	U3	2003-12-12
DK200300222U3	Denmark	U3	2003-12-12
NZ519926A	New Zealand	A	2004-02-27
AT6739U1	Austria	U1	2004-03-25
NZ528520A	New Zealand	A	2004-08-27
AU779452B2	Australia	B2	2005-01-27
EP1246827B1	European Patent Office (EPO)	B1	2005-04-13
AT293113T	Austria	T	2005-04-15
ATE293113T1This record	Austria	T1	2005-04-15
DE60019461D1	Germany	D1	2005-05-19
DK1246827T3	Denmark	T3	2005-05-23
PT1246827E	Portugal	E	2005-08-31
DE60019461T2	Germany	T2	2005-09-22
ES2240215T3	Spain	T3	2005-10-16
US7022698B2	United States of America	B2	2006-04-04
CA2395774C	Canada	C	2009-09-15

2 legal events, as the office reported them to INPADOC

Point at a mark for the event

Legal events, newest first
	Event	Code
2009-09-15	Ceased due to non-payment of the annual feeCeasedREN	REN
2005-11-15	Publication of translation of european patent specificationUEP	UEP

CPC, 3: C07D495/04
A61K31/551
A61P25/18
Filled: the office’s first classification
IPC, 3: A61K31 551
A61P25 18
C07D495 04

New polymorphic forms of olanzapine